Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-08-13

Clinical Trial Update: SOLAR & ATRILAZE Atrial Fibrillation Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for atrial fibrillation called SOLAR & ATRILAZE is listed, with the current status shown as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATRILAZE

Snippet

Sponsor: EndoPhotonix, Inc. | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN